Back to R2 link
Top Industry News
- FDA Guidance on Controlled Correspondence Related to Generic Drug Development
- MHRA Guidance on Apply for a Licence to Market a Medicine in the UK
- FDA Guidance on Evaluation of Thermal Effects of Medical Devices that Produce Tissue Heating and/or Cooling
- USDA Finalizes Rule for 'Product of USA' Label Claim on Meat, Poultry, and Egg Products
- FDA Completes Voluntary Market Phase-Out of PFAS in Food Packaging
- ANVISA Updates Normative Instruction on Food Supplement Constituents and Labeling Requirements
- ANVISA - SCMED Provides Guidance on Submitting the Drug Marketing Report
- FDA - Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act
- MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
- FDA Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program
- FDA Draft Guidance on Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs
- FDA Draft Guidance on Annual Reportable Labeling Changes for NDAs and ANDAs for Nonprescription Drug Products
- ECHA Proceeds with Evaluation of Proposal to Restrict PFAS in Europe
- US Laboratory Discovers High Temperatures Can Elevate Benzene Levels in Benzoyl Peroxide Products"
- SAG-CS Final Opinion on Methyl Salicylate